2017年12月8日，加州戴维斯 Marrone生物创新公司. (纳斯达克:MBII) (MBI), a leading provider of bio-based pest management 和 plant health products for agriculture, 草坪及装饰及水处理市场, today announced the launch 和 availability of a high-performance 和 cost-effective biological fungicide, 振幅™, 在2018年的生长季节. 使用与最近EPA批准的Stargus™相同的活性成分, 振幅扩大使用这种令人兴奋的新产品大英亩bte365官网在线投.
振幅是基于一种新的解淀粉芽孢杆菌菌株, 发现的MBI, that has shown strong performance against white molds 和 soil diseases such as Phytophthora, 丝核菌(马铃薯粉腐病和黑头皮屑), 和镰刀菌素, 正如美国的田间试验所示.S.、加拿大及欧洲.
在评估市场时, MBI has identified that growers have often struggled to find great performing products for white mold in those important crops. They have few choices of products that perform well on the group of fungi that causes white molds on pulses, 干豆, 灯泡的蔬菜, 大豆, 油菜和向日葵. 振幅™, 哪一个解决了这个特定的市场需求, 是MBI定向筛选发现计划的直接结果. This product is also complementary 和 additive to the broad spectrum of diseases covered by MBI’s first biofungicide, 徽章®, 为控制白霉菌和土壤疾病提供了强有力的双重打击. MBI 和 partners also are testing this Bacillus-based product for seed treatment applications.
“We are pleased to provide growers with this unique tool to control white molds 和 soil diseases on a broad range of large acre crops, 以及脉搏, 块茎和块根bte365官网在线投. The development of this product is particularly timely in light of the development of resistance to conventional fungicide products. 振幅可以单独使用, 还可以与传统杀菌剂结合使用，获得较高的投资回报率,André Trépanier说, MBI市场总监. “白霉在这些bte365官网在线投中往往是一种毁灭性的疾病, 如果不加以控制，往往会造成重大的经济损失.”
Tests conducted at MBI’s research 和 development lab show that 振幅™ works by colonizing a plant’s root hairs, stems 和 other surfaces to prevent establishment of fungal 和 bacterial pathogens, 包括 镰刀菌，菌核菌，丝核菌，黄萎病菌，疫病菌 和 菌核. 测试结果还表明，这种细菌产生天然化合物, 其中一些抑制细菌和真菌的菌丝生长, 以及孢子萌发. 除了, the bacteria trigger systemic acquired resistance 和 induced systemic responses in the plant, creating a healthier 和 stronger plant to ward off diseases 和 promote plant health, 生长和增产. MBI已经获得了用于振幅™的新菌株的专利.
Extensive field studies with growers have confirmed 和 demonstrated excellent efficacy against white mold on various pulse crops, 大豆, 向日葵、油菜, 以及甜菜上的褐斑病. Testing for soil applications on potatoes for control of Rhizoctonia (Black scurf) 和 Phytophthora erythroseptica (pink rot) have also delivered excellent results. Successful field trials have been conducted in the United States, Mexico、加拿大及欧洲.
The biofungicide product has also been submitted to Canada 和 Mexico for approval 和 the dossier is being prepared for the European Union. In the United States, pulse crop 和 potato acres affected by white mold increase yearly. 在豆类bte365官网在线投，如扁豆，产量损失很容易达到50%. 加拿大和欧洲预计将增长.300万加6.2017年分别种植700万公顷的油菜1; white mold is the most serious disease facing these crops.
1 Canola Council of Canada, European Commission on Agriculture 和 Rural 发展
聪明的. 自然. 解决方案.
Marrone生物创新公司. (NASDAQ: MBII) strives to lead the movement to a more sustainable world through the discovery, development 和 promotion of biological products for pest management 和 plant health. MBI’s effective 和 environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health 和 increasing crop yields. MBI目前有7种市售产品(徽章®, Gr和evo®, 崇敬®, Majestene®, 还® Stargus™ 和 Zequanox®) as well as seven product c和idates in various stages of the company’s rapid development pipeline. MBI还销售Bio-tam 2.0®Isagro美国和Jet- ag®喷气收获在美国大多数地区.S.
马伦生物创新 is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers 和 consumers around the globe. 欲了解更多信息，请访问www.www.laneyjane.com.
This press release contains forward-looking statements that involve substantial risks 和 uncertainties. 所有的报表, 除了陈述历史事实外, 包括在本新闻稿关于战略, 未来运作及计划, 包括这些陈述背后的假设, 是前瞻性陈述, 且不应被视为代表MBI的任何后续日期的观点. Examples of such statements include statements regarding the potential of 振幅 in the market, 市场预测, 包括振幅的潜在好处, 以及MBI扩大额外标签使用和国际扩张的计划. Such forward-looking statements are based on information available to the Company as of the date of this release 和 involve a number of risks 和 uncertainties, 有些超出了公司的控制范围, that could cause actual results to differ materially from those anticipated by these forward-looking statements, 包括消费者, 影响MBI产品需求的监管和其他因素, any difficulty in marketing MBI’s products in its target markets inside 和 outside the United States, 虫害治理产品的市场竞争, lack of underst和ing of bio-based pest management products by customers 和 growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI没有义务这么做, 并明确声明对, 更新或改变本版本中包含的前瞻性声明, 是否是当前信息的结果, 未来事件或其他.